McClellan Statement on the Supreme Court’s Decision to Hear Mifepristone Case | Congresswoman Jennifer McClellan
Skip to main content

McClellan Statement on the Supreme Court’s Decision to Hear Mifepristone Case

December 13, 2023

Washington, D.C. – Today, Congresswoman Jennifer McClellan (VA-04) issued the following statement after the Supreme Court’s decision to grant certiorari in the case Alliance for Hippocratic Medicine v. FDA: 

“Today, the United States Supreme Court agreed to hear Alliance for Hippocratic Medicine v. FDA. While this is an important step in the continued fight for reproductive freedom, the future of mifepristone remains uncertain. The lower courts’ rulings attempting to limit access to  mifepristone are outrageous, undermine the FDA’s authority, and jeopardize the health and well-being of millions of Americans. 

“Mifepristone is proven to be a safe, effective abortion medication and remains accessible to Americans for now. I signed onto an amicus brief with more than 200 of my congressional colleagues to urge the Court to preserve access to mifepristone. I will continue fighting to protect Americans’ reproductive freedoms and empower them to make their own health care decisions in consultation with their providers. Politicians have no place in these deeply personal, medical choices. We have seen the impact of these attacks on abortion rights, causing horrific situations like Kate Cox’s case in Texas or Brittany Watts in Ohio.

“We must continue to oppose these systematic attacks on reproductive health care to ensure the health and well-being of every American.”